To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC7775 | Bradanicline (TC-5619) Featured |
Bradanicline (TC-5619) is an experimental pharmaceutical drugthat acts as a partial agonist at the α7 subtype of the neural nicotinic acetylcholine receptors.
More description
|
|
| DC70563 | LEO 134310 Featured |
LEO 134310 (LP 0155) is a non-steroidal, potent and selective glucocorticoid receptor (GR) agonist (EC50=2 nM, hPBMC)
More description
|
|
| DC71032 | DS-3801b Featured |
DS-3801b is a potent and non-macrolide agonist of GPR38. DS-3801b is expected to be novel gastrointestinal prokinetic agents for the research of functional gastrointestinal disorders such as gastroparesis and chronic constipation.
More description
|
|
| DC49082 | CDK5-IN-2 Featured |
CDK5-IN-2 (compound 15) is a highly selective CDK5 inhibitor with IC50s of 0.2 and 23 for CDK5/p25 and CDK2/CycA, respectively.
More description
|
|
| DC48099 | Fipravirimat Featured |
Fipravirimat is a potent HIV-1 inhibitor. Fipravirimat has the potential for HIV and AIDS research.
More description
|
|
| DC70220 | Asundexian Featured |
Asundexian, also known as BAY2433334 and BI1265162, is a blood coagulation factor XIa inhibitor. Asundexian binds directly to the active site of FXIa and thereby inhibits its activity.
More description
|
|
| DC34200 | Nelivaptan Featured |
Nelivaptan is a non-peptide vasopressin receptor antagonist that is selective for the V1B subtype.
More description
|
|
| DC46967 | Baxdrostat Featured |
Baxdrostat is a aldosterone synthase inhibitor.
More description
|
|
| DC71308 | GB1211 Featured |
GB1211 is an orally available galectin-3 (Gal-3) inhibitor.
More description
|
|
| DC48132 | Bexotegrast Featured |
Bexotegrast is a potent inhibitor of ανβ6 integrin. Bexotegrast can be used for researching fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP) (extracted from patent WO2020210404A1, compound 5).
More description
|
|
| DC72339 | PF-07258669 Featured |
PF-07258669 is a melanocortin-4 receptor (MC4) antagonist. PF-07258669 can be used for the research of cachexia, anorexia, or anorexia nervosa.
More description
|
|
| DC47260 | Zunsemetinib Featured |
Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases.
More description
|
|
| DC33647 | CM-4620 Featured |
CM-4620 is a calcium-release activated calcium-channel (CRAC channel) inhibitor, with IC50s of 119 nM, 895 nM for Orai1/STIM1 and Orai2/STIM1 channels, respectively.
More description
|
|
| DC21124 | HS-38 Featured |
HS-38 is a potent and selective DAPK1 and DAPK3 (ZIPK) inhibitor with IC50 of 200 nM for DAPK1 and Kd of 280 nM for ZIPK, also inhibits Pim3 (IC50=200 nM), and displays no activity against Src or Abl, little activity against EGFR;
More description
|
|
| DC70662 | NPX-800 Featured |
NPX-800 is a potent, selective, oral heat shock factor 1 (HSF1) pathway inhibitor.
More description
|
|
| DC11649 | Jamaicin (AnCoA4) Featured |
AnCoA4 (AnCoA-4, AnCoA 4) is a potent Orai1 channel inhibitor that inhibits store-operated calcium (SOC) with EC50 of 0.88 uM.
More description
|
|
| DC72779 | RK-701 Featured |
RK-701 is an highly selective and non-genotoxic inhibitor of G9a with IC50 value of 23-27 nM. RK-701 selectively up-regulates HbF, γ- Globin, BGLT3 expression, down-regulates H3K9me2 expression. RK-701 also has inhibition for BCL11A and ZBTB7A.
More description
|
|
| DC44837 | M4205 Featured |
M4205 is a c-KIT inhibitor, with an IC50 of 10 nM for c-KIT V654A. M4205 has high activity on c-KIT mutations in exon 11, 13, 17.
More description
|
|
| DC72365 | BAY-390 Featured |
BAY-390 is a selective, across species active and brain penetrating TRPA1 inhibitor. BAY-390 inhibits hTRPA1 FLIPR, hTRPA1 Ephys, rTRPA1 FLIPR and rDRG Ephys with IC50s of 16, 82, 63 and 35 nM, respectively.
More description
|
|
| DC72785 | TP0597850 Featured |
TP0597850 is a selective inhibitor of MMP2 (IC50=0.22 nM). TP0597850 has a long MMP2 dissociation half-life (t1/2=265 min).
More description
|
|
| DC22954 | MG-624 Featured |
MG624 is a potent and selective neuronal α7 nAChR antagonist with a Ki of 106 nM.
More description
|
|
| DC11382 | NYX-2925 Featured |
NYX-2925 is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and Memory.
More description
|
|
| DC34373 | N2-OH-PhIP Featured |
N2-OH-PhIP is a PhIP metabolite.
More description
|
|
| DC71735 | PCLX-001 Featured |
PCLX-001 is an orally acitve, small-molecule, dual N-myristoyltransferase (NMT) inhibitor, with IC50s of 5 nM (NMT1) and 8 nM (NMT2), respectively.
More description
|
|
| DC72649 | Nimucitinib Featured |
Nimucitinib is a Janus kinase (JAK) inhibitor.
More description
|
|
| DC11954 | JP-153 Featured |
JP-153 (JP153) is a novel small molecule targets the Src-FAK-Paxillin signaling, inhibits Src-dependent phosphorylation of paxillin (Y118) and downstream activation of Akt (S473) in RECs; potently inhibits VEGF-induced proliferation and migration, inhibits retinal neovascularization in the murine oxygen-induced retinopathy model.
More description
|
|
| DC23142 | GW274150 Featured |
GW274150 is a novel arginine-competitive, NADPH-dependent iNOS inhibitor that has been identified from a series of acetamide amino acids that have a high selectivity for iNOS vs both eNOS (> 260-fold) and nNOS (> 219-fold) and high bioavailability (> 90%) after oral administration.Target: iNOSin vivo: GW274150 demonstrates a narrow neuroprotective therapeutic window against the toxic actions of 6-OHDA. GW274150 administration leads to a dose-dependent decrease in the number of iNOS-positive cells in the SNc of the 6-OHDA-lesioned animals. The iNOS inhibitor GW274150 fails to produce long-term neuroprotection after its withdrawal in the 6-OHDA-lesioned rat. [1]
More description
|
|
| DC70491 | HPPE Featured |
HPPE is a specific nonelectrophilic and physiological Bach1 inhibitor via heme-binding sites of Bach1 protein, derepresses Bach1-mediated repression.HPPE induces up-regulation of Hmox1 mRNA is mediated by Bach1 inhibition in vivo.
More description
|
|
| DC7288 | SB-657510 Featured |
Selective urotensin-II (UT) receptor antagonist (Ki values are 61, 17, 30, 65 and 56 nM at human, monkey, cat, rat and mouse receptors respectively). Inhibits U-II-induced intracellular Ca2+ mobilization (IC50 = 180 nM) and antagonizes the contractile act
More description
|
|
| DC42357 | NF-κΒ activator 1 Featured |
NF-κΒ activator 1 is a potent NF-κΒ activator with an EC50 of 0.9 μM. NF-κΒ activator 1 induces superoxide dismutase (SOD) 2 mRNA expression.
More description
|
|